Concepedia

Salvage (Re)radiation in Oligometastatic and Oligorecurrent Cervical Cancer

Supriya Chopra, Babusha Kalra, Jaahid Mulani, Jeevanshu Jain, Lavanya Gurram, Prachi Mittal, Mitali Alone, Jaya Ghosh, Sushmita Rath, Seema Gulia,

International Journal of Radiation Oncology*Biology*Physics · 2022 · 10 citations · 22 references

DOI

Concepts

References

22

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.9K citations

, , +15

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Hyun Cheol Chung, Willeke Ros, Jean‐Pierre Delord et al. · Journal of Clinical Oncology · 2019 · 1.1K citations · Full text

, , +17

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Nicoletta Colombo, Coraline Dubot, Domenica Lorusso et al. · New England Journal of Medicine · 2021 · 992 citations · Full text

, , +17

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al. · The Lancet · 2017 · 679 citations · Full text

, , +6

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 641 citations · Full text

, , +13